IL-2 antibodies in type 1 diabetes and during IL-2 therapy

被引：6
作者：
Churlaud, Guillaume [1 ,2 ,3 ]
Rosenzwajg, Michelle [1 ,2 ,3 ]
Cacoub, Patrice [1 ,2 ,3 ,4 ]
Saadoun, David [1 ,2 ,3 ,4 ]
Valteau-Couanet, Dominique [5 ]
Chaput, Nathalie [6 ,7 ,8 ]
Pugliese, Alberto [9 ,10 ,11 ]
Klatzmann, David [1 ,2 ,3 ]
机构：
[1] Grp Hosp Pitie Salpetriere, AP HP, Biotherapy CIC BTi, Paris, France
[2] Inflammat Immunopathol Biotherapy Dept i2B, Paris, France
[3] Sorbonne Univ, INSERM, Immunol Immunopathol Immunotherapy, 83 Bd Hop, F-75651 Paris, France
[4] Grp Hosp Pitie Salpetriere, AP HP, Dept Internal Med & Clin Immunol, Natl Reference Ctr Autoimmune Syst & Rare Dis, Paris, France
[5] Gustave Roussy, Dept Pediat, Villejuif, France
[6] Inst Gustave Roussy, CNRS, UMS 3655, Inst Gustave Roussy,Lab Immunomonitoring Oncol, Villejuif, France
[7] INSERM, US23, Villejuif, France
[8] Univ Paris Sud, UFR Pharm, Chatenay Malabry, France
[9] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA
[10] Univ Miami, Miller Sch Med, Dept Med, Div Endocrinol & Metab, Miami, FL 33136 USA
[11] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA
来源：
DIABETOLOGIA | 2018年 / 61卷 / 09期
关键词：
Autoantibodies; Autoimmune disease; Autoimmunity; IL-2; Type; 1; diabetes; LOW-DOSE INTERLEUKIN-2; BINDING; PHASE; SERA;
D O I：
10.1007/s00125-018-4649-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2066 / 2068
页数：3
相关论文
共 10 条
[1]   Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial [J].
Hartemann, Agnes ;
Bensimon, Gilbert ;
Payan, Christine A. ;
Jacqueminet, Sophie ;
Bourron, Olivier ;
Nicolas, Nathalie ;
Fonfrede, Michele ;
Rosenzwajg, Michelle ;
Bernard, Claude ;
Klatzmann, David .
LANCET DIABETES & ENDOCRINOLOGY, 2013, 1 (04) :295-305
[2]   The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases [J].
Klatzmann, David ;
Abbas, Abul K. .
NATURE REVIEWS IMMUNOLOGY, 2015, 15 (05) :283-294
[3]   Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific [J].
Marzinotto, Ilaria ;
Liberati, Daniela ;
Brigatti, Cristina ;
Bonfanti, Riccardo ;
Stabilini, Angela ;
Monti, Paolo ;
Bosi, Emanuele ;
Piemonti, Lorenzo ;
Lampasona, Vito .
DIABETOLOGIA, 2017, 60 (09) :1834-1835
[4]   Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis [J].
Meager, A ;
Wadhwa, M ;
Dilger, P ;
Bird, C ;
Thorpe, R ;
Newsom-Davis, J ;
Willcox, N .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 132 (01) :128-136
[5]   Loss of immune tolerance to IL-2 in type 1 diabetes [J].
Perol, Louis ;
Lindner, John M. ;
Caudana, Pamela ;
Nunez, Nicolas Gonzalo ;
Baeyens, Audrey ;
Valle, Andrea ;
Sedlik, Christine ;
Loirat, Delphine ;
Boyer, Olivier ;
Creange, Alain ;
Cohen, Jose Laurent ;
Rogner, Ute Christine ;
Yamanouchi, Jun ;
Marchant, Martine ;
Leber, Xavier Charles ;
Scharenberg, Meike ;
Gagnerault, Marie-Claude ;
Mallone, Roberto ;
Battaglia, Manuela ;
Santamaria, Pere ;
Hartemann, Agnes ;
Traggiai, Elisabetta ;
Piaggio, Eliane .
NATURE COMMUNICATIONS, 2016, 7
[6]   Treatment-induced antibodies to interleukin-2 [J].
Prummer, O .
BIOTHERAPY, 1997, 10 (01) :15-24
[7]   Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients [J].
Rosenzwajg, Michelle ;
Churlaud, Guillaume ;
Mallone, Roberto ;
Six, Adrien ;
Derian, Nicolas ;
Chaara, Wahiba ;
Lorenzon, Roberta ;
Long, S. Alice ;
Buckner, Jane H. ;
Afonso, Georgia ;
Pham, Hang-Phuong ;
Hartemann, Agnes ;
Yu, Aixin ;
Pugliese, Alberto ;
Malek, Thomas R. ;
Klatzmann, David .
JOURNAL OF AUTOIMMUNITY, 2015, 58 :48-58
[8]   Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis [J].
Saadoun, David ;
Rosenzwajg, Michelle ;
Joly, Florence ;
Six, Adrien ;
Carrat, Fabrice ;
Thibault, Vincent ;
Sene, Damien ;
Cacoub, Patrice ;
Klatzmann, David .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (22) :2067-2077
[9]   INTERLEUKIN-A BINDING-PROTEINS IN SERA FROM NORMAL SUBJECTS AND MULTIPLE-SCLEROSIS PATIENTS [J].
TROTTER, JL ;
DAMICO, CA ;
TROTTER, AL ;
COLLINS, KG ;
CROSS, AH .
NEUROLOGY, 1995, 45 (11) :1971-1974
[10]   High avidity cytokine autoantibodies in health and disease: Pathogenesis and mechanisms [J].
Watanabe, Masato ;
Uchida, Kanji ;
Nakagaki, Kazuhide ;
Trapnell, Bruce C. ;
Nakata, Koh .
CYTOKINE & GROWTH FACTOR REVIEWS, 2010, 21 (04) :263-273
1